omicSynth:一个开放的多基因社区资源,用于识别神经退行性疾病中的可药物标
Chelsea X Alvarado1, Mary B Makarious2, Cory A Weller1
1Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20814, USA; Data Tecnica LLC, Washington, DC 20037, USA.
American journal of human genetics
|January 5, 2024
概括
这项研究使用孟德尔随机化确定了阿尔茨海默症和帕金森症等神经退行性疾病的新型遗传标. 一个新的框架有助于药物发现和重新利用这些条件.
科学领域:
- 遗传学和生物信息学 遗传学和生物信息学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经退行性疾病缺乏有效的治疗方法,需要新的治疗点.
- 人口老龄化增加了对疾病修饰疗法的需求.
- 最近的FDA批准强调了生物机制与治疗发现之间的联系.
研究的目的:
- 建立一个开放的,基于证据的框架,用于确定神经退行性疾病的治疗点.
- 为了利用遗传数据用于药物发现和重新利用计划.
- 提供有关疾病过程和治疗网络效应的机制性见解.
主要方法:
- 基于总结数据的门德尔随机化被用来识别遗传目标.
- 使用pSMR_multi < 2.95 × 10^-6和pHEIDI > 0.01.1来确定统计学意义.
- 鉴定出来的基因根据药用性和现有的治疗方法进行了分类.
主要成果:
- 确定了116种阿尔茨海默病,46种帕金森病,3种ALS,5种LBD和9种PSP目标基因.
- 分类了41个新目标,3个已知的目标和115个困难目标.
- 69.8%的新标体表达在与疾病相关的细胞类型中.
结论:
- 这些新发现的新基因为药物发现和重新利用提供了新的途径.
- 对药物基因网络的分析建议进一步研究现有药物,例如阿尔茨海默病中的瑞卢.
- 提供了一个用户友好的网络平台,以促进社区对治疗目标的探索.
相关概念视频
01:26Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
02:26Protein Networks
4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
01:26Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K